- £43.11bn
- £48.06bn
- $34.95bn
- 93
- 36
- 85
- 84
C2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28,132 | 27,587 | 29,206 | 32,723 | 34,949 |
Cost of Revenue | |||||
Gross Profit | 9,279 | 9,416 | 9,827 | 10,815 | 11,963 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25,339 | 25,324 | 25,879 | 29,013 | 30,763 |
Operating Profit | 2,793 | 2,263 | 3,327 | 3,710 | 4,186 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,181 | 1,664 | 3,102 | 3,461 | 4,014 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,647 | 1,165 | 2,452 | 2,699 | 3,089 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,716 | 1,122 | 2,630 | 3,862 | 3,178 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,716 | 1,122 | 2,630 | 3,862 | 3,178 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.21 | 2.01 | 3.09 | 3.69 | 4.68 |
Dividends per Share |